Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1994;15(6):303–306. doi: 10.1007/BF02339241

Crohn's disease and multiple sclerosis: A single case report

G P Buccino 1, G Corrente 2, D Visintini 1,✉
PMCID: PMC7088006  PMID: 7843946

Abstract

A case of the association of multiple sclerosis and Crohn's disease in a 47 year old patient is reported.

A possible relationship between these two diseases has been widely documented, both sporadically and at a familial level.

Albeit in the absence of precise experimental data, it is legitimate to presume that the two diseases share common pathogenetic traits

Key Words: multiple sclerosis, Crohn's disease, incidence, immunological findings

References

  • [1].Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Co-operative Crohn's disease study. Gastroenterology. 1976;70:439–44. [PubMed] [Google Scholar]
  • [2].Brynskov J., Tvede N.:Plasma interleukin-2 and soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease: effect of ciclosporine. Gut, 795–799, 1990. [DOI] [PMC free article] [PubMed]
  • [3].Fuhwara M., Mitsui K., Ishida J., Yamamoto I. The effect of salazosulfapyridine on in vitro antibody production in murine spleen cells. Immunopharmacology. 1990;19:15–21. doi: 10.1016/0162-3109(90)90022-7. [DOI] [PubMed] [Google Scholar]
  • [4].Gitnik G., Collins J., Beaman B., Brooks D., Arthur M., Imaeda T., Palieschesky M. Preliminary report of isolation of mycobacteria from patients with Crohn's disease. Dig. Dis. Sci. 1989;34:925–32. doi: 10.1007/BF01540280. [DOI] [PubMed] [Google Scholar]
  • [5].Gold R., Kappos L., Backer T. Development of Multiple Sclerosis in patients on long-term sulfasalazine. Lancet. 1990;335:409–409. doi: 10.1016/0140-6736(90)90239-2. [DOI] [PubMed] [Google Scholar]
  • [6].Kitchin L.I., Knobler R.L., Friedman L.S. Crohn's disease in a patient with multiple sclerosis. J. Clin. Gastroenterol. 1991;13:331–331. doi: 10.1097/00004836-199106000-00017. [DOI] [PubMed] [Google Scholar]
  • [7].Knobler R.L., Rodriguez M., Lampert P.W., Oldstrom M.B. Virologic models of chronic relapsing demyelinating disease. Acta Neuropathol. 1983;9:31–31. doi: 10.1007/978-3-642-69094-5_4. [DOI] [PubMed] [Google Scholar]
  • [8].Linderberg E., Jarnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand. J. Gastroenterol. 1991;26:495–500. doi: 10.3109/00365529108998572. [DOI] [PubMed] [Google Scholar]
  • [9].Mahida Y.R., Gallagher A., Kurlak L., Hawkey C.J. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin. Exp. Immunol. 1990;82:75–80. doi: 10.1111/j.1365-2249.1990.tb05406.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Mayberry J., Mann R. Inflammatory bowel disease in rural sub-saharan Africa: rarity of diagnosis in patients attending mission hospitals. Digestion. 1989;44:172–76. doi: 10.1159/000199907. [DOI] [PubMed] [Google Scholar]
  • [11].Minuk J.Y., Lewkonia R.M. Possible familial association of multiple sclerosis and inflammatory bowel disease. N. Engl. J. Med. 1986;314:586–586. doi: 10.1056/NEJM198602273140921. [DOI] [PubMed] [Google Scholar]
  • [12].Moss M.T., Green E.P., Tizard M.L., Mazik Z.P., Hermon-Taylor J. Specific detction of Mycobacterium paratubercolosis by DNA hybridisation with a fragmento of the insertion element IS 900. Gut. 1991;32:395–98. doi: 10.1136/gut.32.4.395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Odes H.S., Fraser D., Krugliac P., Fenyves D., Fraser J.M., Sperber A.D. Inflammatory bowel disease in Bedouin Arabs of southern Israel: rarity of diagnosis and clinical features. Gut. 1991;32:1024–26. doi: 10.1136/gut.32.9.1024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Panitch H.S., Hirsch R.L., Schindler J., Johnson K.P. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology. 1987;37:1097–1102. doi: 10.1212/wnl.37.7.1097. [DOI] [PubMed] [Google Scholar]
  • [15].Poser C.M., Paty D.Y., Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guideline for research protocols. Annals of Neurology. 1983;13:227–227. doi: 10.1002/ana.410130302. [DOI] [PubMed] [Google Scholar]
  • [16].Prosiegel M., Neu I., Vogl S., Hoffmann J., Wildfeuer A., Rubenstroth-Bauer G. Suppression of experimental autoimmune encephalomyelitis by sulfasalazine. Acta Neurol. Scand. 1990;81:237–237. doi: 10.1111/j.1600-0404.1990.tb00973.x. [DOI] [PubMed] [Google Scholar]
  • [17].Purmann J., Arendt G., Cleveland S., Borcard F., Furst W., Gemsa R., Bertrams J., Hengels K.J. Association of Crohn's disease and multiple sclerosis. J. Clin. Gastroenterol. 1992;4:43–43. doi: 10.1097/00004836-199201000-00011. [DOI] [PubMed] [Google Scholar]
  • [18].Raedler A., Shreiber S., Weerh A.D., Boss A., Peter S., Greten H. Assessment of in vitro activated T cells in patients with Crohn's disease. Hepatotogastroenterology. 1990;37:67–71. [PubMed] [Google Scholar]
  • [19].Rang E., Brooke N.B., Taylor H.J. Association of ulcerative colitis with multiple sclerosis. Lancet. 1982;2:555–555. doi: 10.1016/s0140-6736(82)90629-8. [DOI] [PubMed] [Google Scholar]
  • [20].“Epidemiologia della sclerosi multipla” inRosati G., Granieri A.:Manuale di neuroepidemiologia. La Nuova Italia Scientifica 1988.
  • [21].Sadovnik A.D., Paty D.W., Yannakoulios G. Concurrence of multiple sclerosis and inflammatory bowel disease. N. Engl. J. Med. 1989;321:762–762. [PubMed] [Google Scholar]
  • [22].Waksman J. (Ed.):Immunological aspects of multiple sclerosis. Res. Immunol., 140:175, 1989. [PubMed]

Articles from Italian Journal of Neurological Sciences are provided here courtesy of Nature Publishing Group

RESOURCES